What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we are expanding access to genomic technology to realize health equity for billions of
Join us to build: we’re seeking entrepreneurially-minded individuals with deep technical and commercial domain expertise, who are eager to solve urgent unmet challenges through venture building. This role offers a unique opportunity to work at the
UE05: £29,588 - £33,951 per annum School of Biological Sciences / Institute of Quantitative Biology / Biochemistry and Biotechnology Full Time: 35 hours per week Fixed term: 12 months fixed term contract (with possibility of extension
Your new company Join a global biopharmaceutical organisation dedicated to transforming patient outcomes across multiple disease areas. Youll be part of a science‑driven environment that values innovation, collaboration, and meaningful impact and work with highly experienced
Research Assistant in Brain Vascular Epigenomics - UK Dementia Research Institute Job Type: Full-Time. Starting Salary: 43863 plus benefits To find out more about the job please click the apply for job button to be taken
Research Associate in Brain Vascular Epigenomics - UK Dementia Research Institute Job Type: Full-Time. Starting Salary: 50733 - 59484 per annum + 50733 plus benefits To find out more about the job please click the apply
The Origin Group Limited (TOGL (Holdings) Ltd) is the parent organisation and technical service provider to a focused portfolio of UK-based medical technology, research, and innovation companies. Organisations within the group include Origin Sciences, Ellele Health
Senior Protein Scientist – Chromatin Biology London, United Kingdom Employment Type: Full-time We are seeking an accomplished Senior Scientist in Chromatin Biology to advance the molecular and biochemical characterisation of our lead clinical candidates across diverse
Mitra Bio is building the future of skincare through epigenetics, longevity science, and AI. We help people better understand their skin over time using non-invasive skin sampling and advanced data analysis. Backed by leading investors and trusted